Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Pearson ADJ"'
Autor:
Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Valent A, Van Roy N, Villamon E, Janousek D, Pribill I, Glogova E, Attiyeh EF, Hogarty MD, Monclair TF, Holmes K, Valteau-Couanet D, Castel V, Tweddle DA, Park JR, Cohn S, Ladenstein R, Beck-Popovic M, De Bernardi B, Michon J, Pearson ADJ, Ambros PF
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
For localized, resectable neuroblastoma without MYCN amplification, surgery only is recommended even if incomplete. However, it is not known whether the genomic background of these tumors may influence outcome.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::43477caef538b2e27cbc66c986f93535
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13330
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13330
Autor:
Pearson, ADJ, Zwaan, C.M., Kolb, EA, Karres, D, Guillot, J, Kim, SY, Marshall, L, Tasian, SK, Smith, M, Cooper, T, Adamson, PC, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, DV, Fogelstrand, L, Fraenkel, PG, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, JH, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G, Vassal, G
Publikováno v:
European journal of cancer
Pearson, A D J, Zwaan, C M, Kolb, E A, Karres, D, Guillot, J, Kim, S Y, Marshall, L, Tasian, S K, Smith, M, Cooper, T, Adamson, P C, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, D V, Fogelstrand, L, Fraenkel, P G, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, J H, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G & Vassal, G 2020, ' Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration ', European Journal of Cancer, vol. 136, pp. 116-129 . https://doi.org/10.1016/j.ejca.2020.04.038
European Journal of Cancer, 136, 116-129. Pergamon
European Journal of Cancer, 136, 116-129. Elsevier Ltd.
Pearson, A D J, Zwaan, C M, Kolb, E A, Karres, D, Guillot, J, Kim, S Y, Marshall, L, Tasian, S K, Smith, M, Cooper, T, Adamson, P C, Barry, E, Benettaib, B, Binlich, F, Borgman, A, Brivio, E, Capdeville, R, Delgado, D, Faller, D V, Fogelstrand, L, Fraenkel, P G, Hasle, H, Heenen, D, Kaspers, G, Kieran, M, Klusmann, J H, Lesa, G, Ligas, F, Mappa, S, Mohamed, H, Moore, A, Morris, J, Nottage, K, Reinhardt, D, Scobie, N, Simko, S, Winkler, T, Norga, K, Reaman, G & Vassal, G 2020, ' Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration ', European Journal of Cancer, vol. 136, pp. 116-129 . https://doi.org/10.1016/j.ejca.2020.04.038
European Journal of Cancer, 136, 116-129. Pergamon
European Journal of Cancer, 136, 116-129. Elsevier Ltd.
Purpose: The current standard-of-care for front-line therapy for acute myeloid leukaemia (AML) results in short-term and long-term toxicity, but still approximately 40% of children relapse. Therefore, there is a major need to accelerate the evaluatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ea901e797ad2961db6c39007f2797adc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85087974955
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85087974955
Autor:
Ambros, I.M., Tonini, G.P., Gross, N., Mosseri, V., Pötschger, U., Beiske, K., Berbegall, A.P., Bénard, J., Bown, N., Caron, H., Combaret, V., Couturier, J., Defferrari, R., Delattre, O., Jeison, M., Kogner, P., Lunec, J., Marques, B., Martinsson, T., Mazzocco, K., Noguera, R., Schleiermacher, G., Valent, A., Van Roy, N., Villamon, E., Janousek, D., Pribill, I., Glogova, E., Attiyeh, E.F., Hogarty, M.D., Monclair, T., Holmes, K., Valteau-Couanet, D., Pearson ADJ, A.D.J., Castel, V., Tweddle, D.A., Park, J.R., Cohn, S., Ladenstein, R., Beck-Popovic, M., De Bernardi, B., Michon, J., Ambros, P.F.
BACKGROUND: Biology based treatment reduction, i.e. surgery alone also in case of not totally resected tumors, was advised in neuroblastoma patients with localized resectable disease without MYCN amplification. However, whether the genomic background
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2016::66b18bf7b74b4a5d7ecf2168fe1bbcf4
https://hdl.handle.net/10400.18/5899
https://hdl.handle.net/10400.18/5899
Autor:
Amoroso, L, Erminio, G, Makin, G, Pearson, ADJ, Brock, P, Valteau-Couanet, D, Castel, V, Pasquet, M, Laureys, G, Thomas, C, Luksch, R, Ladenstein, R, Haupt, R, Garaventa, A, SIOPEN Grp
Publikováno v:
Cancer Research and Treatment
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Purpose Metastatic response to induction therapy for high-risk neuroblastoma is a prognostic factor. In the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN) HR-NBL-1 protocol, only patients with metastatic complete response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::98f58f8aec63c6f7cd0149aee091ebe5
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7987
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7987
Autor:
Morgenstern, Da, London, Wb, Stephens, D, Volchenboum, Sl, Hero, B, DI CATALDO, Andrea, Nakagawara, A, Shimada, H, Ambros, Pf, Matthay, Kk, Cohn, Sl, Pearson, Adj, Irwin, Ms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::10e69127d576f13959d59baadd923213
http://hdl.handle.net/20.500.11769/111697
http://hdl.handle.net/20.500.11769/111697
Autor:
Morgenstern, Da, London, Wb, Stephens, D, Volchenboum, Sl, Hero, B, DI CATALDO, Andrea, Nakagawara, A, Shimada, H, Ambros, Pf, Matthay, Kk, Cohn, Sl, Pearson, Adj, Irwin, M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::9d0367856af36c2ebe08263bb5ebc3c4
http://hdl.handle.net/20.500.11769/107191
http://hdl.handle.net/20.500.11769/107191
Autor:
Beiske, K, Burchill, SA, Cheung, IY, Hiyama, E, Seeger, RC, Cohn, SL, Pearson, ADJ, Matthay, KK, International neuroblastoma Risk Group Task Force
Publikováno v:
British journal of cancer, vol 100, iss 10
Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neuroblastoma. Its accurate and sensitive assessment can facilitate optimal treatment decisions. The International Neuroblastoma Risk Group (INRG) Task Fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7e77de3b980f95f9c3cf0148ac7be798
https://escholarship.org/uc/item/4ps6d5j2
https://escholarship.org/uc/item/4ps6d5j2
Publikováno v:
Blood, 97(2), 393-398. American Society of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1a1d5ef295b5bfbb22c3dd0652b6c57c
https://pure.eur.nl/en/publications/bf6466ca-8a93-4297-8146-af849019c8e8
https://pure.eur.nl/en/publications/bf6466ca-8a93-4297-8146-af849019c8e8
Autor:
Keams, PR, Pieters, Rob, Rottier, MMA, Veerman, AJP, Schmiegalow, K, Pearson, ADJ, Hall, AG, Kaspers, P.J.G.
Publikováno v:
Drug resistance in leukemia an lymphoma III, 211-216
STARTPAGE=211;ENDPAGE=216;TITLE=Drug resistance in leukemia an lymphoma III
STARTPAGE=211;ENDPAGE=216;TITLE=Drug resistance in leukemia an lymphoma III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a298a103d7e3431a0ce8aaf16706f31a
https://pure.eur.nl/en/publications/47d6fc0c-b612-4250-80b6-84f24523a3ce
https://pure.eur.nl/en/publications/47d6fc0c-b612-4250-80b6-84f24523a3ce
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.